Chinese Innovative Assets Trigger New Wave of Global Collaborations at BIOSeedin Summit

Industry
โดย PR Newswire·Read original
Summary · why it matters

On the eve of the BIO International Convention 2026, the BIOSeedin Summer Innovation Partnering Summit in San Diego showcased China's differentiated innovative assets, drawing over 350 registrants and more than 200 on-site attendees from over 30 countries and regions. The summit, hosted by bioSeedin with strategic partners Thermo Fisher Scientific and ACROBiosystems, featured two sessions: one on early-stage strategy and innovation, where panelists emphasized that multinational corporations now view China as a core innovation fountain, and another on late-stage global ecosystems, highlighting that China and AI are permanent structural forces in the industry. Roadshow presentations were delivered by companies including Antengene, GeneScience Pharmaceutical, Salsola Therapeutics, HighTide Therapeutics, and others. The bioSeedin 1on1 Partnering System facilitated nearly 200 face-to-face meetings, reflecting strong interest in cross-border licensing and collaboration.

Impact on stocks 5

Biotech & Genomic Medicine▲ · 3 stocks
HighTide Therapeutics Inc
2511
▲ PositiveDemandrelevance

Presented roadshow; summit highlights cross-border licensing interest, potentially increasing demand for its assets.

Antengene Corp Ltd
6996
▲ PositiveDemandrelevance

Presented roadshow; summit highlights cross-border licensing interest, potentially increasing demand for its assets.

Materials▲ · 1 stocks
Digital Finance & Tokenization▲ · 1 stocks

Off-coverage companies 2

Changchun GeneScience Pharmaceutical Co., Ltd.Private▲ Positive
Demandrelevance

Presented roadshow; summit highlights cross-border licensing interest, potentially increasing demand for its assets.

Salsola TherapeuticsPrivate▲ Positive
Demandrelevance

Presented roadshow; summit highlights cross-border licensing interest, potentially increasing demand for its assets.

© 2026 MarketDXNews